140 related articles for article (PubMed ID: 35143457)
1. Intraductal Papilloma With Carcinoma of the Breast Described by Dedicated Breast 18F-FDG PET.
Noritake M; Yamada A; Yamanaka S; Utsunomiya D; Inoue T
Clin Nucl Med; 2022 Jun; 47(6):557-558. PubMed ID: 35143457
[TBL] [Abstract][Full Text] [Related]
2. Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.
Corbin H; Bomeisl P; Amin AL; Marshall HN; Gilmore H; Harbhajanka A
Hum Pathol; 2022 Oct; 128():90-100. PubMed ID: 35863513
[TBL] [Abstract][Full Text] [Related]
3. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
4. A Case of Intraductal Papilloma of the Breast With High 18F-FDG Uptake on PET/CT.
Jinguji M; Kajiya Y; Nakajo M; Higashi M; Yoshiura T
Clin Nucl Med; 2015 Nov; 40(11):905-7. PubMed ID: 26164173
[TBL] [Abstract][Full Text] [Related]
5. Excision recommended in high-risk patients: Revisiting the diagnosis of papilloma on core biopsy in the context of patient risk.
Chen YA; Mack JA; Karamchandani DM; Zaleski MP; Xu L; Dodge DG; Chetlen AL
Breast J; 2019 Mar; 25(2):232-236. PubMed ID: 30697873
[TBL] [Abstract][Full Text] [Related]
6. Papillary lesions of the breast: To excise or observe?
Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
[TBL] [Abstract][Full Text] [Related]
7. Intraductal papilloma of the breast: F-18 FDG PET demonstration.
Nguyen BD; Lidner TK
Clin Nucl Med; 2005 Jul; 30(7):481-2. PubMed ID: 15965323
[No Abstract] [Full Text] [Related]
8. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
[TBL] [Abstract][Full Text] [Related]
9. Intraductal carcinoma arising in intraductal papilloma in an axillary lymph node: review of the literature and proposed theories of evolution.
Jaffer S; Lin R; Bleiweiss IJ; Nagi C
Arch Pathol Lab Med; 2008 Dec; 132(12):1940-2. PubMed ID: 19061295
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CD56 and CD57 immunostainings for discrimination between endocrine ductal carcinoma in situ and intraductal papilloma.
Tajima S; Maeda I; Kanemaki Y; Nakajima Y; Tatsunami S; Fukuda M; Takagi M
Pathol Int; 2010 Jun; 60(6):459-65. PubMed ID: 20518901
[TBL] [Abstract][Full Text] [Related]
11. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
[TBL] [Abstract][Full Text] [Related]
12. Benign epithelial proliferations in axillary lymph nodes with ipsilateral breast in situ ductal carcinoma and intraductal papilloma of the breast.
Liu M
Histopathology; 2008 May; 52(6):771-3. PubMed ID: 18439159
[No Abstract] [Full Text] [Related]
13. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
[TBL] [Abstract][Full Text] [Related]
14. Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology?
Michael CW; Buschmann B
Cancer; 2002 Apr; 96(2):92-100. PubMed ID: 11954026
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the usefulness of breast strain elastography for intraductal lesions.
Kokubu Y; Yamada K; Tanabe M; Izumori A; Kato C; Horii R; Ohno S; Matsueda K
J Med Ultrason (2001); 2021 Jan; 48(1):63-70. PubMed ID: 33389371
[TBL] [Abstract][Full Text] [Related]
16. Papillary lesions of the breast - review and practical issues.
Ni Y; Tse GM
Semin Diagn Pathol; 2022 Sep; 39(5):344-354. PubMed ID: 35718581
[TBL] [Abstract][Full Text] [Related]
17. Upgrade rate of intraductal papilloma without atypia on breast core needle biopsy: A clinical, radiological and pathological correlation study.
Genco IS; Tugertimur B; Manolas PA; Hasanovic A; Hajiyeva S
Am J Surg; 2020 Sep; 220(3):677-681. PubMed ID: 32007236
[TBL] [Abstract][Full Text] [Related]
18. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ.
Furuya C; Kawano H; Yamanouchi T; Oga A; Ueda J; Takahashi M
Pathol Int; 2012 Jun; 62(6):381-90. PubMed ID: 22612506
[TBL] [Abstract][Full Text] [Related]
19. [Histopathological diagnosis of papillary lesion of the breast].
Akiyama F; Sakamoto G
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():32-5. PubMed ID: 7747989
[TBL] [Abstract][Full Text] [Related]
20. [Study of CD44v6 protein expression in intraductal papilloma and its malignant transformation of breast].
He JH; Liang XM; Hou JH; Huan YL; Wu QL; Xiao YB
Ai Zheng; 2002 Jun; 21(6):615-8. PubMed ID: 12452061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
